“Interim Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes”, J of Skin, vol. 6, no. 6, pp. 458–462, Nov. 2022, doi: 10.25251/skin.6.6.2.